Nantermet Pascale, Harada Shun-ichi, Liu Yuan, Cheng Spring, Johnson Colena, Yu Yuanjiang, Kimme Donald, Holder Daniel, Hodor Paul, Phillips Robert, Ray William J
Department of Alzheimer's Disease Research, Merck Research Laboratories, West Point, PA 19486, USA.
Endocrinology. 2008 Apr;149(4):1551-61. doi: 10.1210/en.2007-1151. Epub 2008 Jan 10.
Androgens increase muscle mass, decrease fat mass, and reduce high-density lipoprotein cholesterol (HDL), but the relationship between body composition, lipoprotein metabolism, and androgens has not been explained. Here we treated ovariectomized cynomolgus monkeys with 5alpha-dihydrotestosterone (DHT) or vehicle for 14 d and measured lipoprotein and triglycerides. Nuclear magnetic resonance analysis revealed that DHT dose-dependently reduced the cholesterol content of large HDL particles and decreased mean HDL particle size (P < 0.01) and also tended to lower low-density lipoprotein cholesterol without altering other lipoprotein particles. Liver and visceral fat biopsies taken before and after DHT treatment for 1 or 14 d were analyzed by genome-wide microarrays. In liver, DHT did not alter the expression of most genes involved in cholesterol synthesis or uptake but rapidly increased small heterodimer partner (SHP) RNA, along with concomitant repression of CYP7A1, a target of SHP transcriptional repression and the rate-limiting enzyme in bile acid synthesis. DHT regulation of SHP and CYP7A1 also occurs in rats, indicating a conserved mechanism. In adipose tissue, pathway analyses suggested coordinate regulation of adipogenesis, tissue remodeling, and lipid homeostasis. Genes encoding IGF-I and beta-catenin were induced, as were extracellular matrix, cell adhesion, and cytoskeletal components, whereas there was consistent down-regulation of genes involved in triacylglycerol metabolism. Interestingly, cholesterol ester transfer protein RNA was induced rapidly in monkey adipose tissue, whereas its inhibitor apolipoprotein CI was repressed. These data provide insight into the androgenic regulation of lipoprotein homeostasis and suggest that changes in adipose lipoprotein metabolism could contribute to HDL cholesterol reduction.
雄激素可增加肌肉量、减少脂肪量并降低高密度脂蛋白胆固醇(HDL),但身体成分、脂蛋白代谢与雄激素之间的关系尚未阐明。在此,我们用5α-双氢睾酮(DHT)或赋形剂处理去卵巢食蟹猴14天,并测量脂蛋白和甘油三酯。核磁共振分析显示,DHT剂量依赖性地降低了大HDL颗粒的胆固醇含量,减小了平均HDL颗粒大小(P < 0.01),并且还倾向于降低低密度脂蛋白胆固醇,而不改变其他脂蛋白颗粒。对DHT处理1天或14天前后采集的肝脏和内脏脂肪活检组织进行全基因组微阵列分析。在肝脏中,DHT并未改变参与胆固醇合成或摄取的大多数基因的表达,但迅速增加了小异二聚体伴侣(SHP)RNA,同时抑制了CYP7A1,CYP7A1是SHP转录抑制的靶点以及胆汁酸合成中的限速酶。DHT对SHP和CYP7A1的调节在大鼠中也存在,表明存在保守机制。在脂肪组织中,通路分析提示对脂肪生成、组织重塑和脂质稳态的协同调节。编码IGF-I和β-连环蛋白的基因被诱导,细胞外基质、细胞黏附和细胞骨架成分相关基因也被诱导,而参与三酰甘油代谢的基因则持续下调。有趣的是,胆固醇酯转运蛋白RNA在猴脂肪组织中迅速被诱导,而其抑制剂载脂蛋白CI则被抑制。这些数据为脂蛋白稳态的雄激素调节提供了见解,并表明脂肪脂蛋白代谢的变化可能导致HDL胆固醇降低。